Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2031.41	-788.05	36.97
Graham Fair Price	31.76	12.91	9.80
PEG	799.42	0.12	0.01
Price/Book	-7.18	0.52	0.56
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-37.48	4.69	7.50
Price/Sales	-25.87	5.12	6.90
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.44	0.97	1.00
Operating Margin	37.18	0.38	0.28
ROA	51.80	< 0.005	< 0.005
ROE	0.02	0.03	48.48
ROIC	< 0.005	0.01	79.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.23	0.15	47.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.78	0.73	-5.45
EPS QOQ	5.50	0.38	-93.05
FCF QOQ	1.00	0.00	inf
Revenue QOQ	-0.10	0.26	161.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.65	0.59	-9.69
Quick Ratio	9.88	10.51	6.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.09	16.32	8.13
Cash	21.12	20.04	-5.11
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	1.23	1.66	35.39
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	9.88	10.51	6.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.69	-215.87	1193.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating